Close
Close

AstraZeneca - NF type1 With Inoperable Plexiform Neurofibromas

Partner

Not provided

Rare Disease

NF type1 With Inoperable Plexiform Neurofibromas

Sponsor

AstraZeneca

Access Program Information

This will be an open-label, single-arm, multicenter intermediate access protocol which provides treatment access to selumetinib for eligible patients with neurofibromatosis type 1 (NF1) who have inoperable, progressive/symptomatic plexiform neurofibromas (PN) without any alternative therapeutic options. All patients will continue to receive drug while they are deriving clinical benefit . Approximately 50 patients in the US will be treated as part of this protocol

Contact
Locations
  • United States
  • Birmingham, Alabama, United States
  • United States
  • Hartford, Connecticut, United States
  • United States
  • Washington, District of Columbia, United States
  • United States
  • Tampa, Florida, United States
  • United States
  • Indianapolis, Indiana, United States
  • United States
  • New Orleans, Louisiana, United States
  • New Orleans, Louisiana, United States
  • United States
  • Ann Arbor, Michigan, United States
  • Grand Rapids, Michigan, United States
  • United States
  • Minneapolis, Minnesota, United States
  • United States
  • Saint Louis, Missouri, United States
  • United States
  • Lincoln, Nebraska, United States
  • United States
  • Albany, New York, United States
  • United States
  • Durham, North Carolina, United States
  • United States
  • Cincinnati, Ohio, United States
  • Cleveland, Ohio, United States
  • United States
  • Oklahoma City, Oklahoma, United States
  • United States
  • Portland, Oregon, United States
  • United States
  • Philadelphia, Pennsylvania, United States
  • United States
  • Memphis, Tennessee, United States
  • United States
  • Houston, Texas, United States
  • San Antonio, Texas, United States
  • San Antonio, Texas, United States
  • United States
  • Salt Lake City, Utah, United States
  • United States
  • Richmond, Virginia, United States
  • United States
  • Milwaukee, Wisconsin, United States

Free Newsletter